Omers Administration Corp Capricor Therapeutics, Inc. Transaction History
Omers Administration Corp
- $12.3 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
138Shares Held
12.6MCall Options Held
4.95MPut Options Held
5.57M-
Vanguard Group Inc Valley Forge, PA2.21MShares$13.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$9.85 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$8.87 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$5.83 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.33 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $147M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...